Fibrinogen and Fibrin in Hemostasis and Thrombosis.

Despite its recognition as a key component of blood clots, the roles of fibrinogen and fibrin (collectively fibrin[ogen]) in hemostasis and thrombosis are insufficiently understood. Consequently, fibrin(ogen) remains an active focus of investigation at all levels of the research spectrum, including fundamental basic/discovery science, epidemiology, and clinical practice and applications. This article briefly reviews basic biology and biochemistry of fibrinogen and fibrin formation, structure, and stability and highlights recent studies published in Arteriosclerosis, Thrombosis, and Vascular Biology and elsewhere. These have enhanced our understanding of fibrin(ogen) and revealed new potential applications for fibrin detection in thrombosis. The fibrinogen molecule is a 340-kDa homodimeric glycoprotein consisting of 2Aα, 2Bβ, and 2γ polypeptide chains linked by 29 disulfide bridges. Fibrinogen synthesis occurs primarily in hepatocytes (Figure 1). Assembly of the 6 chains takes place in a stepwise manner in which single chains assemble first into Aα-γ and Bβ-γ complexes, then into Aα/Bβ/γ half-molecules, and finally into hexameric complexes (Aα/Bβ/γ)2.1 All 6 fibrinogen chains are assembled with their N termini located in a central E nodule and extend outward in a coiled-coil arrangement. The Bβ and γ chains terminate in globular regions known as βC and γC modules, respectively. These regions collectively comprise the so-called D nodule. The Aα chains are the longest; at the end of the coiled-coil region, each chain extends into a highly flexible series of repeats followed by a globular αC region. Using high-resolution atomic force microscopy, Protopopova et al2 obtained striking images of fibrinogen that visualize each of these structural components. Figure 1. Fibrinogen synthesis and expression. Fibrinogen synthesis is regulated by both transcriptional and translational mechanisms. After individual fibrinogen chains are translated, fibrinogen assembly occurs stepwise. Single chains assemble first into Aα-γ and Bβ-γ precursors, then into Aα/Bβ/γ half-molecules, and finally into hexameric complexes (Aα/Bβ/γ) …

[1]  H. Gaylis Venous thrombosis. , 2020, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

[2]  P. Boor,et al.  Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis. , 2017, Journal of the American Society of Nephrology : JASN.

[3]  C. Haynes,et al.  Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. , 2017, Blood.

[4]  R. Pawlinski,et al.  In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. , 2017, Blood.

[5]  J. Weisel,et al.  Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[6]  A. Undas,et al.  Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[7]  A. Fogelson,et al.  Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Wolberg,et al.  The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits. , 2016, Blood.

[9]  Marco M. Domingues,et al.  Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network , 2016, Thrombosis and Haemostasis.

[10]  A. Gruber,et al.  Factor XI as a Therapeutic Target , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[11]  F. Leebeek,et al.  Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII , 2016, Journal of thrombosis and haemostasis : JTH.

[12]  P. de Moerloose,et al.  The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders , 2016, Seminars in Thrombosis & Hemostasis.

[13]  S. Diamond,et al.  Transport physics and biorheology in the setting of hemostasis and thrombosis , 2016, Journal of thrombosis and haemostasis : JTH.

[14]  R. Porte,et al.  Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen , 2016, Journal of thrombosis and haemostasis : JTH.

[15]  J. Heemskerk,et al.  Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[16]  V. Schroeder,et al.  Factor XIII: Structure and Function , 2016, Seminars in Thrombosis & Hemostasis.

[17]  D. Harats,et al.  Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[18]  C. Maas,et al.  Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Philippou,et al.  Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[20]  Marco M. Domingues,et al.  Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing. , 2016, Blood.

[21]  Lorna M. Lopez,et al.  A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. , 2016, Human molecular genetics.

[22]  J. Weisel,et al.  Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. , 2016, Blood.

[23]  J. Weisel,et al.  Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots , 2015, Scientific Reports.

[24]  D. Dwivedi,et al.  Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[25]  A. Folsom,et al.  Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[26]  D. Weitz,et al.  Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure , 2015, Thrombosis and Haemostasis.

[27]  W. Lam,et al.  Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. , 2015, Blood.

[28]  D. Izquierdo-Garcia,et al.  Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Uwe Völker,et al.  Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. , 2015, Blood.

[30]  A. Casini,et al.  Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management , 2015, Journal of thrombosis and haemostasis : JTH.

[31]  Stephanie A. Smith,et al.  2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[32]  M. Budoff,et al.  Relationship of Cigarette Smoking With Inflammation and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[33]  D. Klinov,et al.  Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high‐resolution AFM , 2015, Journal of thrombosis and haemostasis : JTH.

[34]  S. Diamond,et al.  Fibrin, &ggr;′-Fibrinogen, and Transclot Pressure Gradient Control Hemostatic Clot Growth During Human Blood Flow Over a Collagen/Tissue Factor Wound , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[35]  G. Raskob,et al.  Factor XI antisense oligonucleotide for prevention of venous thrombosis. , 2014, The New England journal of medicine.

[36]  A. Houng,et al.  Microvascular Thrombosis, Fibrinolysis, Ischemic Injury, and Death After Cerebral Thromboembolism Are Affected by Levels of Circulating &agr;2-Antiplasmin , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[37]  S. Diamond,et al.  A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity. , 2014, Blood.

[38]  D. Dwivedi,et al.  Neutrophil Extracellular Traps Promote Thrombin Generation Through Platelet-Dependent and Platelet-Independent Mechanisms , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[39]  K. Brummel-Ziedins,et al.  Global assays of hemostasis , 2014, Current opinion in hematology.

[40]  W. Lam,et al.  Factor XIII activity mediates red blood cell retention in venous thrombi. , 2014, Journal of Clinical Investigation.

[41]  B. Monia,et al.  Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic Plaques , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[42]  Betti Giusti,et al.  Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[43]  A. Wolberg,et al.  Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency , 2014, Journal of thrombosis and haemostasis : JTH.

[44]  René M. Botnar,et al.  Fibrin-Targeted Magnetic Resonance Imaging Allows In Vivo Quantification of Thrombus Fibrin Content and Identifies Thrombi Amenable for Thrombolysis , 2014, Arteriosclerosis, Thrombosis and Vascular Biology.

[45]  W. Bergmeier,et al.  The fibrinogen γA/γ′ isoform does not promote acute arterial thrombosis in mice , 2014, Journal of thrombosis and haemostasis : JTH.

[46]  É. Katona,et al.  Interaction of factor XIII subunits. , 2014, Blood.

[47]  L. Rauova,et al.  Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. , 2014, Blood.

[48]  M. Poncz,et al.  Modulation of Protein C Activation by Histones, Platelet Factor 4, and Heparinoids: New Insights Into Activated Protein C Formation , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[49]  B. Lämmle,et al.  Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. , 2013, Journal of vascular surgery. Venous and lymphatic disorders.

[50]  A. Wolberg,et al.  Elevated Prothrombin Promotes Venous, but Not Arterial, Thrombosis in Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[51]  A. Gruber,et al.  Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[52]  T. Orfeo,et al.  Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. , 2012, Blood.

[53]  D. Cook,et al.  Prognostic utility and characterization of cell-free DNA in patients with severe sepsis , 2012, Critical Care.

[54]  S. Connell,et al.  Evidence that fibrinogen γ′ directly interferes with protofibril growth: implications for fibrin structure and clot stiffness , 2012, Journal of thrombosis and haemostasis : JTH.

[55]  B. Polack,et al.  Antithrombin-Independent Effects of Heparins on Fibrin Clot Nanostructure , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[56]  Elie A Akl,et al.  Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[57]  R. Ajjan,et al.  Clot Architecture Is Altered in Abdominal Aortic Aneurysms and Correlates With Aneurysm Size , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[58]  Paul J. Harrison,et al.  Differential contributions of monocyte‐ and platelet‐derived microparticles towards thrombin generation and fibrin formation and stability , 2011, Journal of thrombosis and haemostasis : JTH.

[59]  Kiril Tenekedjiev,et al.  Lytic Resistance of Fibrin Containing Red Blood Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[60]  A. Wolberg,et al.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. , 2011, Blood.

[61]  K. Tenekedjiev,et al.  Hindered dissolution of fibrin formed under mechanical stress , 2011, Journal of thrombosis and haemostasis : JTH.

[62]  A. Balmforth,et al.  Interactions between factor XIII and the alphaC region of fibrinogen. , 2011, Blood.

[63]  S. Lord,et al.  Molecular Mechanisms Affecting Fibrin Structure and Stability , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[64]  I. Komáromi,et al.  Factor XIII: novel structural and functional aspects , 2011, Journal of thrombosis and haemostasis : JTH.

[65]  J. Weisel,et al.  Flow rate and fibrin fiber alignment , 2010, Journal of thrombosis and haemostasis : JTH.

[66]  S. Antonarakis,et al.  Regulation of fibrinogen production by microRNAs. , 2010, Blood.

[67]  Robert A. Campbell,et al.  Flow profoundly influences fibrin network structure: Implications for fibrin formation and clot stability in haemostasis , 2010, Thrombosis and Haemostasis.

[68]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[69]  N. Santos,et al.  Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. , 2010, ACS nano.

[70]  P. Holt,et al.  Indications for Catheter-Directed Thrombolysis in the Management of Acute Proximal Deep Venous Thrombosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[71]  Z. Siudak,et al.  Altered Plasma Fibrin Clot Properties Are Associated With In-Stent Thrombosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[72]  D. Margosan,et al.  Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure: An Ex Vivo Investigation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[73]  J. Weisel,et al.  Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes , 2009, Thrombosis and Haemostasis.

[74]  Alisa S Wolberg,et al.  Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. , 2009, Blood.

[75]  W. Tracz,et al.  Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. , 2009, Blood.

[76]  U. Seligsohn Factor XI deficiency in humans , 2009, Journal of thrombosis and haemostasis : JTH.

[77]  O. McCarty,et al.  Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. , 2009, Blood.

[78]  H. Weiler,et al.  Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin‐binding γ′ chain sequence , 2009, Journal of thrombosis and haemostasis : JTH.

[79]  Alisa S Wolberg,et al.  Cellular Procoagulant Activity Dictates Clot Structure and Stability as a Function of Distance From the Cell Surface , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[80]  O. McCarty,et al.  γA/γ’ fibrinogen inhibits thrombin-induced platelet aggregation , 2008, Thrombosis and Haemostasis.

[81]  M. Hoffman Alterations of fibrinogen structure in human disease. , 2008, Cardiovascular & hematological agents in medicinal chemistry.

[82]  T. Wakefield,et al.  Mechanisms of venous thrombosis and resolution. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[83]  J. Weitz,et al.  Bivalent Binding to γA/γ′-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex* , 2008, Journal of Biological Chemistry.

[84]  S. Lord,et al.  B:b interactions are essential for polymerization of variant fibrinogens with impaired holes ‘a’ 1 , 2007, Journal of thrombosis and haemostasis : JTH.

[85]  James H Morrissey,et al.  Polyphosphate enhances fibrin clot structure. , 2007, Blood.

[86]  S. Hanson,et al.  Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway , 2007, British journal of haematology.

[87]  J. Weisel Structure of fibrin: impact on clot stability , 2007, Journal of thrombosis and haemostasis : JTH.

[88]  Alisa S Wolberg,et al.  Thrombin generation and fibrin clot structure. , 2007, Blood reviews.

[89]  A. Hamsten,et al.  Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors , 2007, Journal of thrombosis and haemostasis : JTH.

[90]  P. Simpson‐Haidaris,et al.  Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndrome , 2007 .

[91]  M. Horne,et al.  The effect of red blood cells on thrombin generation , 2006, British journal of haematology.

[92]  J. Houwing-Duistermaat,et al.  Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. , 2005, Blood.

[93]  Alisa S Wolberg,et al.  High dose factor VIIa improves clot structure and stability in a model of haemophilia B , 2005, British journal of haematology.

[94]  L. Almasy,et al.  A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[95]  R. Hantgan,et al.  Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis , 2004, Microscopy and Microanalysis.

[96]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[97]  J. Oliver,et al.  Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system , 2004, Journal of thrombosis and haemostasis : JTH.

[98]  J. Weisel,et al.  Influence of &ggr;′ Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[99]  R. Ariëns,et al.  Fibrinogen gamma-chain splice variant γ′ alters fibrin formation and structure , 2003 .

[100]  Sergiy Yakovlev,et al.  Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site. , 2003, Biochemistry.

[101]  M. Blombäck,et al.  The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX , 2003, Journal of thrombosis and haemostasis : JTH.

[102]  J. Weisel,et al.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk , 2003, The Lancet.

[103]  A. Wolberg,et al.  Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. , 2003, Blood.

[104]  P. Grant,et al.  Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease , 2002, Circulation.

[105]  A. Wolberg,et al.  Analyzing fibrin clot structure using a microplate reader , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[106]  H. Ni,et al.  Association of (cid:2) A/ (cid:2) ’ Fibrinogen Levels and Coronary Artery Disease , 2022 .

[107]  S. Brennan,et al.  The Amino Acid Sequence in Fibrin Responsible for High Affinity Thrombin Binding , 2001, Thrombosis and Haemostasis.

[108]  J. Soria,et al.  Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[109]  I. Mochalkin,et al.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[110]  L. Lorand,et al.  Structural origins of fibrin clot rheology. , 1999, Biophysical journal.

[111]  J. Herbert,et al.  Contribution of Erythrocytes to Thrombin Generation in Whole Blood , 1999, Thrombosis and Haemostasis.

[112]  R. Doolittle,et al.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.

[113]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[114]  K. Carlsson,et al.  Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. , 1994, Thrombosis research.

[115]  E. Davie,et al.  Factor XI deficiency in Ashkenazi Jews in Israel. , 1991, The New England journal of medicine.

[116]  W. Stüber,et al.  A Photometric Assay for Blood Coagulation Factor XIII , 1991, Thrombosis and Haemostasis.

[117]  C. Francis,et al.  Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. , 1988, Blood.

[118]  W. Kane,et al.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.

[119]  R. D'Agostino,et al.  Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.

[120]  D. Dhall,et al.  Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development. , 1986, Thrombosis research.

[121]  G. Crabtree,et al.  Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. , 1984, The Journal of biological chemistry.

[122]  E. Davie,et al.  gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. , 1984, Biochemistry.

[123]  S. Olexa,et al.  FIBRIN POLYMERIZATION SITES IN FIBRINOGEN AND FIBRIN FRAGMENTS * , 1983, Annals of the New York Academy of Sciences.

[124]  M. Mosesson,et al.  Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[125]  C. Francis,et al.  Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen. , 1980, The Journal of biological chemistry.

[126]  L. McIntire,et al.  Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition. , 1975, The Journal of laboratory and clinical medicine.

[127]  O. McCarty,et al.  gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation. , 2008, Thrombosis and haemostasis.

[128]  J. Weitz,et al.  Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. , 2008, The Journal of biological chemistry.

[129]  R. Bertina,et al.  Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome. , 2007, Journal of thrombosis and haemostasis : JTH.

[130]  R. Bertina,et al.  Fibrinogen gamma in ischemic stroke: a case-control study , 2007 .

[131]  R. Ariëns,et al.  Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. , 2003, Blood.

[132]  H. Ni,et al.  Association of gammaA/gamma' fibrinogen levels and coronary artery disease. , 2002, Thrombosis and haemostasis.

[133]  J. Martinez,et al.  The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains. , 1983, Blood.

[134]  K. Mann Prothrombin activation. , 1974, Human pathology.

[135]  Stephanie A. Smith,et al.  Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis Polyphosphate : A Novel Modulator of Hemostasis and Thrombosis , 2022 .